Monoclonal Antibodies That Distinguish Inner Core, Outer Core, and Lipid A Regions of Pseudomonas Aeruginosa Lipopolysaccharide

Overview

Journal J Bacteriol

Publisher American Society for Microbiology

Specialty Microbiology

Date 1994 Dec 1

PMID 7525538

Citations 18

Authors

T R de Kievit

J S Lam

Affiliations

Soon will be listed here.

Abstract

In order to examine the immunochemistry of the core-lipid A region of Pseudomonas aeruginosa lipopolysaccharide (LPS), monoclonal antibodies (MAbs) specific for this region were produced in mice. Immunogen was prepared by coating a rough mutant of P. aeruginosa with column-purified core oligosaccharide fractions in order to enhance the immune response to the LPS core-lipid A region. Fourteen hybridoma clones were isolated, characterized, and further divided into three groups on the basis of their reactivities to rough LPS antigens in both enzyme-linked immunosorbent assays and Western immunoblots. In addition, another MAb, 18-19, designated group 1, was included in this study for defining core-lipid A epitopes. MAb 18-19 recognizes the LPS core-plus-one O-repeat unit of the serologically cross-reactive P. aeruginosa O2, O5, and O16. Group 2 MAbs are specific for the LPS outer core region and reacted with P. aeruginosa O2, O5, O7, O8, O10, O16, O18, O19, and O20, suggesting that these serotypes share a common outer core type. Group 3 MAbs recognize the inner core region and reacted with all 20 P. aeruginosa serotypes as well as with other Pseudomonas species, revealing the conserved nature of this region. Group 4 MAbs are specific for lipid A and reacted with all gram-negative organisms tested. Immunoassays using these MAbs and well-defined rough mutants, in addition to the recently determined P. aeruginosa core structures, have allowed us to precisely define immunodominant epitopes within the LPS core region.

Citing Articles

High prevalence of lipopolysaccharide mutants and R2-Pyocin susceptible variants in populations sourced from cystic fibrosis lung infections.

Mei M, Pheng P, Kurzeja-Edwards D, Diggle S bioRxiv. 2023; .

PMID: 37163048 PMC: 10168318. DOI: 10.1101/2023.04.26.538445.

Analysis of the Plasmid-Based Allele of Reveals Its Function in Regulation of Cell Morphology and Biosynthesis of Core Lipopolysaccharide in Pseudomonas aeruginosa.

Yang Z, Zhang Z, Zhu J, Ma Y, Wang J, Liu J Appl Environ Microbiol. 2022; 88(14):e0048022.

PMID: 35762790 PMC: 9317947. DOI: 10.1128/aem.00480-22.

Antibody Binding to the O-Specific Antigen of Pseudomonas aeruginosa O6 Inhibits Cell Growth.

Richard G, MacKenzie C, Henry K, Vinogradov E, Hall J, Hussack G Antimicrob Agents Chemother. 2020; 64(4).

PMID: 32015038 PMC: 7179301. DOI: 10.1128/AAC.02168-19.

Pseudomonas aeruginosa ventilator-associated pneumonia management.

Ramirez-Estrada S, Borgatta B, Rello J Infect Drug Resist. 2016; 9:7-18.

PMID: 26855594 PMC: 4725638. DOI: 10.2147/IDR.S50669.

Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System.

Poole K, Lau C, Gilmour C, Hao Y, Lam J Antimicrob Agents Chemother. 2015; 59(12):7276-89.

PMID: 26369970 PMC: 4649153. DOI: 10.1128/AAC.01785-15.

References

Rivera M, Bryan L, Hancock R, McGroarty E . Heterogeneity of lipopolysaccharides from Pseudomonas aeruginosa: analysis of lipopolysaccharide chain length. J Bacteriol. 1988; 170(2):512-21. PMC: 210683. DOI: 10.1128/jb.170.2.512-521.1988. View

Pollack M, Raubitschek A, Larrick J . Human monoclonal antibodies that recognize conserved epitopes in the core-lipid A region of lipopolysaccharides. J Clin Invest. 1987; 79(5):1421-30. PMC: 424413. DOI: 10.1172/JCI112970. View

Knirel YuA , Vinogradov E, Kocharova N, Paramonov N, Kochetkov N, DMITRIEV B . The structure of O-specific polysaccharides and serological classification of Pseudomonas aeruginosa (a review). Acta Microbiol Hung. 1988; 35(1):3-24. View

Pollack M, Chia J, Koles N, Miller M, Guelde G . Specificity and cross-reactivity of monoclonal antibodies reactive with the core and lipid A regions of bacterial lipopolysaccharide. J Infect Dis. 1989; 159(2):168-88. DOI: 10.1093/infdis/159.2.168. View

Rivera M, McGroarty E . Analysis of a common-antigen lipopolysaccharide from Pseudomonas aeruginosa. J Bacteriol. 1989; 171(4):2244-8. PMC: 209888. DOI: 10.1128/jb.171.4.2244-2248.1989. View

Yokota S, Ochi H, Ohtsuka H, Kato M, Noguchi H . Heterogeneity of the L-rhamnose residue in the outer core of Pseudomonas aeruginosa lipopolysaccharide, characterized by using human monoclonal antibodies. Infect Immun. 1989; 57(6):1691-6. PMC: 313341. DOI: 10.1128/iai.57.6.1691-1696.1989. View

Priest B, Brinson D, Schroeder D, Dunn D . Treatment of experimental gram-negative bacterial sepsis with murine monoclonal antibodies directed against lipopolysaccharide. Surgery. 1989; 106(2):147-54; discussion 154-5. View

Young L, Gascon R, Alam S, Bermudez L . Monoclonal antibodies for treatment of gram-negative infections. Rev Infect Dis. 1989; 11 Suppl 7:S1564-71. DOI: 10.1093/clinids/11.supplement_7.s1564. View

Lesse A, Campagnari A, Bittner W, Apicella M . Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Immunol Methods. 1990; 126(1):109-17. DOI: 10.1016/0022-1759(90)90018-q. View

10.

LIU P, Wang S . Three new major somatic antigens of Pseudomonas aeruginosa. J Clin Microbiol. 1990; 28(5):922-5. PMC: 267837. DOI: 10.1128/jcm.28.5.922-925.1990. View

11.

Lam J, Handelsman M, Chivers T, Macdonald L . Monoclonal antibodies as probes to examine serotype-specific and cross-reactive epitopes of lipopolysaccharides from serotypes O2, O5, and O16 of Pseudomonas aeruginosa. J Bacteriol. 1992; 174(7):2178-84. PMC: 205836. DOI: 10.1128/jb.174.7.2178-2184.1992. View

12.

Rivera M, Chivers T, Lam J, McGroarty E . Common antigen lipopolysaccharide from Pseudomonas aeruginosa AK1401 as a receptor for bacteriophage A7. J Bacteriol. 1992; 174(7):2407-11. PMC: 205868. DOI: 10.1128/jb.174.7.2407-2411.1992. View

13.

Yokota S, Terashima M, Chiba J, Noguchi H . Variable cross-reactivity of Pseudomonas aeruginosa lipopolysaccharide-code-specific monoclonal antibodies and its possible relationship with serotype. J Gen Microbiol. 1992; 138(2):289-96. DOI: 10.1099/00221287-138-2-289. View

14.

Nelson J, Barclay G, MICKLEM L, Poxton I, Govan J . Production and characterisation of mouse monoclonal antibodies reactive with the lipopolysaccharide core of Pseudomonas aeruginosa. J Med Microbiol. 1992; 36(5):358-65. DOI: 10.1099/00222615-36-5-358. View

15.

Kastowsky M, Gutberlet T, BRADACZEK H . Molecular modelling of the three-dimensional structure and conformational flexibility of bacterial lipopolysaccharide. J Bacteriol. 1992; 174(14):4798-806. PMC: 206278. DOI: 10.1128/jb.174.14.4798-4806.1992. View

16.

Chen L, Coleman Jr W . Cloning and characterization of the Escherichia coli K-12 rfa-2 (rfaC) gene, a gene required for lipopolysaccharide inner core synthesis. J Bacteriol. 1993; 175(9):2534-40. PMC: 204554. DOI: 10.1128/jb.175.9.2534-2540.1993. View

17.

Kazemi M, Huntenburg C, Bubbers J . Lipopolysaccharide epitope specificity and binding cross reactivity of the human IgM anti-lipid A monoclonal antibody SdJ5-1.17.15. Mol Immunol. 1993; 30(10):895-902. DOI: 10.1016/0161-5890(93)90013-2. View

18.

Di Padova F, Brade H, Barclay G, Poxton I, Liehl E, SCHUETZE E . A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infect Immun. 1993; 61(9):3863-72. PMC: 281087. DOI: 10.1128/iai.61.9.3863-3872.1993. View

19.

Fujihara Y, Bogard W, Lei M, Daddona P, Morrison D . Monoclonal anti-lipid A IgM antibodies HA-1A and E-5 recognize distinct epitopes on lipopolysaccharide and lipid A. J Infect Dis. 1993; 168(6):1429-35. DOI: 10.1093/infdis/168.6.1429. View

20.

Emori T, Gaynes R . An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 1993; 6(4):428-42. PMC: 358296. DOI: 10.1128/CMR.6.4.428. View